Few & Far Between

By: Chris O'Brien
  • Summary

  • Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for conversations on the cutting edge - from clinical research and policymakers to rare disease advocates and industry leaders.
    © 2023
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Episode 47 - Marc Lajoie, CEO at Outpace Bio
    Dec 31 2024

    "If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at Outpace Bio

    Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Marc Lajoie, as they discuss how de novo proteins can be used to reprogram immune cells.

    Tune in today!

    Show more Show less
    48 mins
  • Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris
    Dec 12 2024

    "It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they are not destroyed during nebulization." - Dr. Carsten Rudolph, CEO and Managing Director at Ethris

    Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Dr. Carsten Rudolph, as they discuss the current state and bright future of nasal vaccine technology.

    Tune in today!

    Show more Show less
    37 mins
  • Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics
    Oct 23 2024

    "We don't endeavor to make elite athletes better. We endeavor to make society healthier." - Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics

    Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Jonathan Scheiman, as they discuss microbiome solutions for next generation health and longevity.

    Tune in today!

    Show more Show less
    44 mins

What listeners say about Few & Far Between

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.